Cibc World Markets Corp Vertex Pharmaceuticals Inc Transaction History

Cibc World Markets Corp

$13.5 Billion
Q3 2024

A detailed history of Cibc World Markets Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cibc World Markets Corp holds 40,674 shares of VRTX stock, worth $18.3 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

40,674

Previous 51,928 21.67%

Holding current value

$18.3 Million

Previous $24.3 Million 22.28%

% of portfolio

0.14%

Previous 0.16%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$460.0 - $505.78 $5.18 Million - $5.69 Million	-11,254 Reduced 21.67%	40,674 $18.9 Million
Q2 2024 Aug 12, 2024	BUY	$392.81 - $485.53 $3.56 Million - $4.4 Million	9,069 Added 21.16%	51,928 $24.3 Million
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $19.8 Million - $21.7 Million	-48,560 Reduced 53.12%	42,859 $17.9 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $16.3 Million - $19.5 Million	47,483 Added 108.07%	91,419 $37.2 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $2.64 Million - $2.83 Million	-7,821 Reduced 15.11%	43,936 $15.3 Million
Q2 2023 Aug 04, 2023	BUY	$314.42 - $351.91 $11.2 Million - $12.6 Million	35,671 Added 221.75%	51,757 $18.2 Million
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $4.86 Million - $5.54 Million	-17,144 Reduced 51.59%	16,086 $5.07 Million
Q4 2022 Feb 09, 2023	BUY	$285.76 - $321.48 $8.38 Million - $9.43 Million	29,339 Added 754.02%	33,230 $9.6 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $7.73 Million - $8.62 Million	-28,220 Reduced 87.88%	3,891 $1.13 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $6.49 Million - $8.08 Million	-27,629 Reduced 46.25%	32,111 $9.05 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $13.2 Million - $15.6 Million	59,740 New	59,740 $15.6 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $12.2 Million - $15.4 Million	-68,765 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $8.7 Million - $9.74 Million	47,986 Added 230.94%	68,765 $12.5 Million
Q2 2021 Aug 10, 2021	SELL	$187.49 - $221.1 $20.8 Million - $24.5 Million	-110,750 Reduced 84.2%	20,779 $4.19 Million
Q1 2021 May 07, 2021	BUY	$207.02 - $241.31 $12.5 Million - $14.6 Million	60,367 Added 84.83%	131,529 $28.3 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $5.24 Million - $6.98 Million	25,297 Added 55.16%	71,162 $16.8 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $932,611 - $1.11 Million	3,648 Added 8.64%	45,865 $12.5 Million
Q2 2020 Aug 12, 2020	SELL	$225.48 - $295.8 $6.89 Million - $9.04 Million	-30,555 Reduced 41.99%	42,217 $12.3 Million
Q1 2020 May 12, 2020	BUY	$199.77 - $247.81 $4.27 Million - $5.3 Million	21,379 Added 41.6%	72,772 $17.3 Million
Q4 2019 Feb 13, 2020	SELL	$166.71 - $223.91 $8.37 Million - $11.2 Million	-50,204 Reduced 49.41%	51,393 $11.3 Million
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $7.16 Million - $8.06 Million	43,073 Added 73.6%	101,597 $17.2 Million
Q2 2019 Aug 13, 2019	SELL	$164.61 - $190.37 $440,167 - $509,049	-2,674 Reduced 4.37%	58,524 $10.7 Million
Q1 2019 May 14, 2019	SELL	$163.73 - $194.7 $14.7 Million - $17.4 Million	-89,538 Reduced 59.4%	61,198 $11.3 Million
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $11.2 Million - $14.2 Million	73,901 Added 96.18%	150,736 $25 Million
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $3.39 Million - $3.89 Million	20,202 Added 35.67%	76,835 $14.8 Million
Q2 2018 Aug 13, 2018	BUY	$145.72 - $169.96 $1.39 Million - $1.63 Million	9,571 Added 20.34%	56,633 $9.63 Million
Q1 2018 May 11, 2018	SELL	$151.6 - $177.13 $4.25 Million - $4.97 Million	-28,065 Reduced 37.36%	47,062 $7.67 Million
Q4 2017 Feb 13, 2018	BUY	$137.28 - $155.55 $2.42 Million - $2.74 Million	17,596 Added 30.59%	75,127 $11.3 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $8.52 Million - $9.33 Million	57,531	57,531 $8.75 Million

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.

Account

Cibc World Markets Corp Vertex Pharmaceuticals Inc Transaction History